MeVis Medical Solutions AG (FRA:M3V) Shares Outstanding (EOP): 1.82 Mil (As of Mar. 2026)


FRA:M3V MeVis Medical Solutions AG FRA:M3V
66 GF Score
Price €24.00
GF Value €22.52
! 4 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG Shares Outstanding (EOP)?

MeVis Medical Solutions AG FRA:M3V 66 Shares Outstanding (EOP) is 1.82 Mil as of Mar. 2026. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. MeVis Medical Solutions AG's shares outstanding for the quarter that ended in Mar. 2026 was 1.82 Mil.

MeVis Medical Solutions AG's quarterly shares outstanding stayed the same from Sep. 2025 (1.82 Mil) to Mar. 2026 (1.82 Mil).

MeVis Medical Solutions AG's annual shares outstanding stayed the same from Sep. 2024 (1.82 Mil) to Sep. 2025 (1.82 Mil).


MeVis Medical Solutions AG  (FRA:M3V) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


MeVis Medical Solutions AG Shares Outstanding (EOP) Related Terms


MeVis Medical Solutions AG Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for MeVis Medical Solutions AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeVis Medical Solutions AG Shares Outstanding (EOP) Chart

MeVis Medical Solutions AG Annual Data
Trend Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.82 1.82 1.82 1.82 1.82

MeVis Medical Solutions AG Semi-Annual Data
Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 1.82 1.82 1.82 1.82

FRA:M3V vs VEEV, BTSG, TEM: Shares Outstanding (EOP) Comparison

For the Health Information Services subindustry, MeVis Medical Solutions AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Shares Outstanding (EOP) falls into.


FRA:M3V
66GF Score
MeVis Medical Solutions AG FRA:M3V
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeVis Medical Solutions AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1.82 Mil mean?
MeVis Medical Solutions AG (FRA:M3V) has a Shares Outstanding (EOP) of 1.82 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on MeVis Medical Solutions AG and its competitors.
Is MeVis Medical Solutions AG's Shares Outstanding (EOP) too high?
MeVis Medical Solutions AG's current Shares Outstanding (EOP) is 1.82 Mil. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Shares Outstanding (EOP) compare to VEEV and BTSG?
MeVis Medical Solutions AG's Shares Outstanding (EOP) of 1.82 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on MeVis Medical Solutions AG and its competitors. MeVis Medical Solutions AG's current Shares Outstanding (EOP) is 1.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Shares Outstanding (EOP) of 1.82 Mil. The stock's GF Value™ is €22.52, compared to a current price of €24.00 — trading 6.6% above its estimated fair value. The current Shares Outstanding (EOP) is 1.82 Mil. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Shares Outstanding (EOP) is 1.82 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €24.00 is trading 6.6% above its estimated GF Value™ of €22.52.

Key valuation signals for FRA:M3V:

  • Shares Outstanding (EOP): 1.82 Mil
  • GF Value™: €22.52 vs. price of €24.00 (6.6% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges 0HI7:UKM3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score

Get the complete analysis for FRA:M3V

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.00
Price
€22.52
GF Value